Icecure Medical Ltd Ordinary Shares ICCM 深 滬
已收盤 09-26 16:00:00 美东时间
1.02
-0.010
-0.97%
華盛通- 最 高1.04
- 今 開1.03
- 成交量 34.15万股
- 最 低 1.02
- 昨 收 1.03
- 總市值 6101.76万
- 52周最高 1.6288
- 市盈率 靜 --
- 換手率 0.57%
- 52周最低 0.471
- 委 比 53.08%
- 總股本 5982.12万
- 歷史最高 12.167
- 量 比 0.47
- 振 幅 1.94%
- 歷史最低 0.471
- 每 手 1
- 風險率 0.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多IceCure Showcases ProSense Cryoablation With Key Studies And Training At The Cardiovascular And Interventional Radiology Society Of Europe Annual Meeting On September 13-17, 2025
Presentations from 5 Key Opinion Leaders on ProSense® cryoablation including 3 independent studies on breast cancer and 1 on endometriosis 3 hands-on training sessions for doctors interested in using
09-22 20:34
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Sept. 16, 2025 /PRNewswire/ -- USA News Group News Commentary – The FDA's accelerated approval of two oncology treatments in August...
09-17 00:29
IceCure Medical Gains Shareholder Approval at Annual Meeting
An update from Icecure Medical ( ($ICCM) ) is now available. On August 20, 2025...
08-21 05:30
HC Wainwright & Co. Maintains Buy on Icecure Medical, Lowers Price Target to $2
HC Wainwright & Co. analyst Yi Chen maintains Icecure Medical (NASDAQ:ICCM) with a Buy and lowers the price target from $2.5 to $2.
08-15 19:39
Icecure Medical Q2 EPS $(0.06) Beats $(0.07) Estimate, Sales $525.000K Miss $662.500K Estimate
Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 7.69 percent. This is unchanged from the same period last year. The company reported
08-13 20:32
Earnings Scheduled For August 13, 2025
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
Examining the Future: Icecure Medical's Earnings Outlook
Icecure Medical (NASDAQ:ICCM) is gearing up to announce its quarterly earnings ...
08-13 03:01
IceCure Medical Completes $10M Rights Offering To Support Tumor-Freezing Technology Expansion
IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor
07-29 21:14
IceCure Medical ProSense Featured At Japanese Breast Cancer Society Conference
Breast surgeon, Professor Eisuke Fukuma, a highly regarded cryoablation expert & ProSense® user at Kameda Medical Center, presented updated breast cancer cryoablation data from an independent study of over
07-25 21:03
